Southeast Asia Bioprocessing Market
$5,998 – $9,998
Deep-dive into Southeast Asia’s biopharma landscape with a comprehensive market & company analysis. Access in-depth market and company analysis of 25 biopharmaceutical companies in Southeast Asia working on various biologics products such as vaccines, monoclonal antibodies, ADCs, biosimilars and cell therapies.
KEY TAKEAWAYS
- Insights into the buying decisions of your potential clients, the key stakeholders and the effect of COVID-19 on their budget and therapeutic pipeline
- Find your potential partners interested in your latest technologies or services offered
- Evaluate your business model by doing a competitive study across various organisations listed
product details
- 1Table of Contents
- 2Companies Mentioned
- 3User Access
SECTION 1
- Preface
- Report scope & data coverage
- IMAPAC’s research methodology
SECTION 2: MARKET OVERVIEW
- Southeast Asia region
- Country-wise – Thailand, Singapore, Malaysia, Indonesia, Vietnam
- Driving factors and limitations for each market
- Scope of growth for each market
SECTION 3: COMPANY OVERVIEW
- Active pipelines
- Partnerships and collaborations
- Technology, equipment and solution providers
- Future expansion plans
SECTION 4: COMPANY ANALYSIS
- Customer profile, market trends and procurement process
- Competition and market tactics
- Companies’ KPI
- Focus applications
- Changes in regulations, per market
- Deciding factors in choosing a vendor
- Factors influencing their buying decisions
- Effect of COVID-19 has on their budget for the next 3 years
- Stakeholders and decision makers for procurement
- Best supplier and the equipment used by their team
- Therapeutic areas having new pipeline in their organization in the next 3 years?
- Interview
- References
SECTION 5
- Bibliography
- Disclaimer
- About us
- Our other reports
THAILAND
- Siam Biosciences
- Government Pharmaceutical Organisation
- Tcels
- Kingen Biotech
- Bio-Net Asia
- Queen Saovabha Memorial Institute
SINGAPORE
- SingCell
- BTI
- Cell Research Corporation
- Tessa Therapeutics
- Dot Bio
- Travecta Therapeutics
- Prestige Biopharma
- Esco Aster
- Lion TCR
MALAYSIA
- Malaysian Vaccine Pharmaceuticals
- National Institutes of Biotechnology Malaysia
INDONESIA
- Biofarma
- PT Kalbe Global Biomedika
- Daewoong Infion
- Bandung Institute of Technology
VIETNAM
- Nanogen Pharmaceutical Biotechnology
- Vietnam Academy of Science and Technology
- Vabiotech
Single - User Access
This license grants the right of use of the purchased report to a single recipient only. You may access the material on your computer, as and when required, for your own personal use.
Multi - User Access
Upto 3 users: This license grants the right of use of the purchased report by upto 3 users of the same firm/enterprise.
Corporate Access
Unlimited user access (Within your organization): This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the number of users.
Related products
$5,998 – $9,998
Asia-Pacific Biologic CMO Facilities
- Region: APAC
- Companies Featured: 42
- Parameters: Facility Design, GMP Certification, Partnerships & Collaborations, Capacity Planning & Future Expansion
- Topics: Biologics Contract Manufacturing Asia-Pacific
$5,998 – $9,998
Asia Pacific Bioprocessing Facilities
- Region: APAC
- Companies Featured: 65
- Parameters: Facility Design, GMP Certification, Partnerships & Collaborations, Capacity Planning & Future Expansion
- Topics: Bioprocessing Facilities Asia-Pacific
Get In Touch
